Bantscheff M - Search Results

1

Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical Proteomics.

Joberty G, Boesche M, Brown JA, Eberhard D, Garton NS, Humphreys PG, Mathieson T, Muelbaier M, Ramsden NG, Reader V, Rueger A, Sheppard RJ, Westaway SM, Bantscheff M, Lee K, Wilson DM, Prinjha RK, Drewes G. Joberty G, et al. Among authors: bantscheff m. ACS Chem Biol. 2016 Jul 15;11(7):2002-10. doi: 10.1021/acschembio.6b00080. Epub 2016 May 19. ACS Chem Biol. 2016. PMID: 27197014

2

Pathway proteomics and chemical proteomics team up in drug discovery.

Hopf C, Bantscheff M, Drewes G. Hopf C, et al. Among authors: bantscheff m. Neurodegener Dis. 2007;4(2-3):270-80. doi: 10.1159/000101851. Neurodegener Dis. 2007. PMID: 17596721 Review.

3

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.

Bantscheff M, Eberhard D, Abraham Y, Bastuck S, Boesche M, Hobson S, Mathieson T, Perrin J, Raida M, Rau C, Reader V, Sweetman G, Bauer A, Bouwmeester T, Hopf C, Kruse U, Neubauer G, Ramsden N, Rick J, Kuster B, Drewes G. Bantscheff M, et al. Nat Biotechnol. 2007 Sep;25(9):1035-44. doi: 10.1038/nbt1328. Epub 2007 Aug 26. Nat Biotechnol. 2007. PMID: 17721511

4

Robust and sensitive iTRAQ quantification on an LTQ Orbitrap mass spectrometer.

Bantscheff M, Boesche M, Eberhard D, Matthieson T, Sweetman G, Kuster B. Bantscheff M, et al. Mol Cell Proteomics. 2008 Sep;7(9):1702-13. doi: 10.1074/mcp.M800029-MCP200. Epub 2008 May 29. Mol Cell Proteomics. 2008. PMID: 18511480 Free PMC article.

5

Proteomics-based strategies in kinase drug discovery.

Bantscheff M, Hopf C, Kruse U, Drewes G. Bantscheff M, et al. Ernst Schering Found Symp Proc. 2007;(3):1-28. doi: 10.1007/2789_2007_060. Ernst Schering Found Symp Proc. 2007. PMID: 18512284 Review.

6

Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care.

Kruse U, Bantscheff M, Drewes G, Hopf C. Kruse U, et al. Among authors: bantscheff m. Mol Cell Proteomics. 2008 Oct;7(10):1887-901. doi: 10.1074/mcp.R800006-MCP200. Epub 2008 Aug 1. Mol Cell Proteomics. 2008. PMID: 18676365 Free article. Review.

7

Revealing promiscuous drug-target interactions by chemical proteomics.

Bantscheff M, Scholten A, Heck AJ. Bantscheff M, et al. Drug Discov Today. 2009 Nov;14(21-22):1021-9. doi: 10.1016/j.drudis.2009.07.001. Epub 2009 Jul 23. Drug Discov Today. 2009. PMID: 19596079 Review.

8

Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays.

Savitski MM, Fischer F, Mathieson T, Sweetman G, Lang M, Bantscheff M. Savitski MM, et al. Among authors: bantscheff m. J Am Soc Mass Spectrom. 2010 Oct;21(10):1668-79. doi: 10.1016/j.jasms.2010.01.012. Epub 2010 Jan 25. J Am Soc Mass Spectrom. 2010. PMID: 20171116 Free article.

9

H-score, a mass accuracy driven rescoring approach for improved peptide identification in modification rich samples.

Savitski MM, Mathieson T, Becher I, Bantscheff M. Savitski MM, et al. Among authors: bantscheff m. J Proteome Res. 2010 Nov 5;9(11):5511-6. doi: 10.1021/pr1006813. Epub 2010 Sep 21. J Proteome Res. 2010. PMID: 20836569

10

Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells.

Kruse U, Pallasch CP, Bantscheff M, Eberhard D, Frenzel L, Ghidelli S, Maier SK, Werner T, Wendtner CM, Drewes G. Kruse U, et al. Among authors: bantscheff m. Leukemia. 2011 Jan;25(1):89-100. doi: 10.1038/leu.2010.233. Epub 2010 Oct 14. Leukemia. 2011. PMID: 20944678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters